Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 4 February 2026

AbbVie stock drops after Rinvoq sales miss, even as 2026 profit forecast tops estimates

AbbVie stock drops after Rinvoq sales miss, even as 2026 profit forecast tops estimates

AbbVie shares fell 2.5% to $219.98 Wednesday after Rinvoq sales missed forecasts, despite the company raising its 2026 profit outlook. Q4 adjusted earnings reached $2.71 per share on $16.618 billion revenue; Skyrizi sales rose 32.5%, while Humira dropped 25.9%. AbbVie announced a three-year Medicaid pact with the Trump administration and pledged $100 billion in U.S. investments.
4 February 2026
···
Lear stock jumps 11% as Q4 results, 2026 cash-flow guide put buybacks back in focus

Lear stock jumps 11% as Q4 results, 2026 cash-flow guide put buybacks back in focus

Lear Corp shares surged 11% to $132.94 after posting a 5% rise in Q4 revenue to $6.0 billion and raising its 2026 outlook. Adjusted EPS climbed to $3.41, but free cash flow fell to $281 million. The company projects 2026 sales of up to $24.01 billion and free cash flow up to $650 million. Other auto-parts stocks also rallied, with Adient up nearly 12%.
4 February 2026
···
AST SpaceMobile (ASTS) stock slides as AT&T taps Amazon Leo for satellite broadband

AST SpaceMobile (ASTS) stock slides as AT&T taps Amazon Leo for satellite broadband

AST SpaceMobile shares fell 10% to $103.73 after AT&T announced a new satellite broadband partnership with AWS and Amazon Leo, focused on business customers. Trading volume topped 15.9 million shares. The drop followed investor concerns over AT&T’s commitment to AST’s direct-to-phone satellite plans. AST’s next satellite launch is scheduled for late February.
4 February 2026
··
Carlisle stock jumps 11% after earnings beat and $1 billion buyback plan

Carlisle stock jumps 11% after earnings beat and $1 billion buyback plan

Carlisle Companies’ shares rose 10.7% to $394 after beating Q4 profit estimates and forecasting low single-digit revenue growth with a 0.50-point margin boost for 2026. Management expects a weak first quarter and flat second quarter, but stronger results in the second half. Q4 revenue was $1.13 billion; adjusted EPS fell to $3.90 from $4.47. The company announced up to $1 billion in buybacks for 2026.
4 February 2026
···
NXP stock rebounds in regular trade as CEO pitches ‘physical AI’ after earnings whipsaw

NXP stock rebounds in regular trade as CEO pitches ‘physical AI’ after earnings whipsaw

NXP Semiconductors shares rose about 2% Wednesday to $225.03, rebounding after a 4.5% drop the previous session. The move followed a first-quarter revenue forecast of $3.05–$3.25 billion, above analyst expectations. CEO Rafael Sotomayor cited “physical AI” as a growth driver for industrial chips. BofA Securities cut its price target to $245 but maintained a buy rating.
4 February 2026
····
TransDigm (TDG) stock falls again as Baird downgrade keeps pressure on share price

TransDigm (TDG) stock falls again as Baird downgrade keeps pressure on share price

TransDigm shares fell 2.3% to $1,271.89 Wednesday after Baird downgraded the stock and cut its price target to $1,400. The company reported a 14% rise in net sales to $2.285 billion for the fiscal first quarter, but net income dropped nearly 10% to $445 million due to higher interest expenses. TransDigm raised its 2026 profit forecast but kept the midpoint below analyst expectations.
4 February 2026
·
Powell Industries stock jumps on strong profit, $1.6 billion backlog and new dividend boost

Powell Industries stock jumps on strong profit, $1.6 billion backlog and new dividend boost

Powell Industries shares jumped 14.5% to $519.02 after reporting fiscal Q1 net income of $41.4 million and revenue of $251.2 million. The company booked $439 million in new orders, closing the quarter with a $1.6 billion backlog. Powell raised its quarterly dividend to $0.27 per share, payable March 18 to shareholders on record Feb. 18.
4 February 2026
···
Boston Scientific stock price skids as key heart-rhythm sales miss jolts BSX

Boston Scientific stock price skids as key heart-rhythm sales miss jolts BSX

Boston Scientific shares fell 15% to $77.83 after quarterly electrophysiology sales missed Wall Street estimates, with Q4 revenue in that segment at $890 million versus a $933 million consensus. Analysts flagged fresh doubts about growth in electrophysiology and Watchman devices. The stock’s drop marked its sharpest one-day decline in over 25 years. Investors await Watchman “CHAMPION” trial data at the ACC.26 meeting in March.
4 February 2026
·
Eaton (ETN) stock slips after cautious 2026 outlook — here’s what investors are watching

Eaton (ETN) stock slips after cautious 2026 outlook — here’s what investors are watching

Eaton shares fell 0.9% to $359.17 Wednesday after the company’s 2026 profit forecast missed Wall Street estimates. Data-center orders in Electrical Americas surged 200% in Q4, but first-quarter margin guidance came in below expectations. Management confirmed plans to spin off the mobility business. Fourth-quarter adjusted EPS reached a record $3.33 on $7.1 billion in sales.
4 February 2026
··
SoFi stock tumbles in regular session as post-upgrade bounce fades — what to watch next

SoFi stock tumbles in regular session as post-upgrade bounce fades — what to watch next

SoFi Technologies shares fell 6.4% to $20.37 Wednesday afternoon, erasing earlier gains after a recent J.P. Morgan upgrade. The drop followed a broader selloff in tech stocks and came days after SoFi posted a strong fourth-quarter profit. Chief Risk Officer Arun Pinto entered a prepaid variable forward contract tied to 71,500 shares, netting about $1.2 million upfront. Investors await next week’s delayed U.S. jobs and inflation reports.
4 February 2026
·
Amazon stock slides ahead of Q4 earnings as Wall Street warns 2026 will be an AI “swing factor”

Amazon stock slides ahead of Q4 earnings as Wall Street warns 2026 will be an AI “swing factor”

Amazon shares fell 2.5% to $232.68 Wednesday, outpacing the Nasdaq-100’s 2.1% drop ahead of Thursday’s earnings report. Analysts expect Q4 sales of $211.56 billion and EPS of $1.98, with AWS revenue forecast at $35.02 billion. Options markets indicate traders are bracing for a 7% swing after results. Raymond James cut its price target to $260, citing AI strategy as key for 2026.
4 February 2026
····
Synopsys stock slips again after Tuesday’s rout as AI disruption fears hit software

Synopsys stock slips again after Tuesday’s rout as AI disruption fears hit software

Synopsys shares fell 1.2% to $414.07 Wednesday afternoon, extending losses after an 8.5% drop Tuesday during a broad software sector selloff. Trading volume Tuesday more than doubled its 50-day average, with the stock now 36% below its July peak. Traders remain defensive, with options activity skewed toward downside bets. Synopsys reports Q1 earnings after markets close on Feb. 25.
4 February 2026
··
1 … 43 44 45 46 47 … 1,172

Stock Market Today

Agricultural Bank of China 601288 A-shares slide as tech rout bites; inflation data is the next test

Agricultural Bank of China 601288 A-shares slide as tech rout bites; inflation data is the next test

7 February 2026
Agricultural Bank of China’s A shares closed down 0.45% at 6.67 yuan in Shanghai Friday, with turnover at 2.24 billion yuan. The bank’s A-share capital remained unchanged at 319.24 billion shares as of Jan. 31. Mainland and Hong Kong stocks fell after a global tech selloff and a sharp drop in silver futures. China’s January CPI data is due Feb. 11, with trading expected to thin ahead of the Lunar New Year break.
Palantir stock price rebounds after AI shakeout — what traders watch next week

Palantir stock price rebounds after AI shakeout — what traders watch next week

7 February 2026
Palantir Technologies shares rose 4.5% to $135.90 Friday after reporting a 70% jump in Q4 revenue to $1.407 billion and forecasting 61% revenue growth in 2026. The stock rebounded from a 6.8% drop Thursday, triggered by concerns over Big Tech capital spending and AI’s impact on software demand. A new partnership with Cognizant and U.S. government policy shifts kept Palantir in focus. Director Alexander D. Moore sold 20,000 shares on Feb. 2.
Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

7 February 2026
Coca-Cola will discontinue its frozen products, including the Minute Maid frozen line, in the U.S. and Canada in Q1 2026. Shares closed Friday up 0.66% at $79.03 ahead of Tuesday’s quarterly results. CEO James Quincey sold 337,824 shares on Feb. 3 for about $26 million under a pre-arranged plan. Options pricing suggests a possible 3% move after earnings.
Go toTop